ID

38210

Beschreibung

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry; ODM derived from: https://clinicaltrials.gov/show/NCT02302742

Link

https://clinicaltrials.gov/show/NCT02302742

Stichworte

Versionen (1)
  1. 27.09.19 27.09.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. September 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02302742

Englisch

Eligibility Breast Cancer NCT02302742

1 Formulare  
Criteria
Beschreibung

Criteria

triple negative breast cancer
Beschreibung

Triple Negative Breast Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1]
C3539878
er/pr <10% and her negative per current asco/cap guidelines
Beschreibung

Estrogen Receptors Percentage | Progesterone Receptors Percentage | Human epidermal growth factor receptor negative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0034804
UMLS CUI [1,2]
C0439165
UMLS CUI [2,1]
C0034833
UMLS CUI [2,2]
C0439165
UMLS CUI [3]
C4087185
stages i-iv
Beschreibung

TNM Breast tumor staging

Datentyp

boolean

Alias
UMLS CUI [1]
C0474926
any age at diagnosis
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
patient must be within 5 years of diagnosis
Beschreibung

Diagnosis Timespan

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0872291
eligible regardless of genetic testing status
Beschreibung

Patient eligible for clinical trial Independent of Genetic testing

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1302261
UMLS CUI [1,2]
C0332291
UMLS CUI [1,3]
C0679560
genetic testing recommended for patients meeting nccn and medicare guidelines
Beschreibung

Genetic testing Recommended

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0679560
UMLS CUI [1,2]
C0034866
and/or
Beschreibung

ID.8

Datentyp

boolean

germline mutation carriers
Beschreibung

Germ-Line Mutation Carrier

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0206530
UMLS CUI [1,2]
C2985478
patients with deleterious or uncertain mutations in hboc genes (brca, pten, p53,-palb2 etc) are eligible regardless of type/site of cancer
Beschreibung

HBOC Genes | BRCA gene | PTEN gene | TP53 gene | PALB2 gene | Patient eligible for clinical trial Independent of Cancer site

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677776
UMLS CUI [1,2]
C0017337
UMLS CUI [2]
C0596223
UMLS CUI [3]
C0694888
UMLS CUI [4]
C0079419
UMLS CUI [5]
C1835898
UMLS CUI [6,1]
C1302261
UMLS CUI [6,2]
C0332291
UMLS CUI [6,3]
C0872338
healthy patients harboring mutations also eligible
Beschreibung

Healthy Volunteers Mutation | Patient eligible for clinical trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1708335
UMLS CUI [1,2]
C0026882
UMLS CUI [2]
C1302261
there is no time limit from the time of diagnosis of cancer and enrollment.
Beschreibung

Time limit Absent | Cancer diagnosis | Enrollment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332186
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0920688
UMLS CUI [3]
C1516879
eligible regardless of personal history of cancer
Beschreibung

Patient eligible for clinical trial Independent of Cancer History

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1302261
UMLS CUI [1,2]
C0332291
UMLS CUI [1,3]
C1512706
exclusion criteria include:
Beschreibung

Exclusion Criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0680251
triple negative breast cancer -patient is not within five years of diagnosis
Beschreibung

Triple Negative Breast Neoplasm Previous

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3539878
UMLS CUI [1,2]
C0205156
germline mutation carriers:
Beschreibung

Germ-Line Mutation Carrier

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0206530
UMLS CUI [1,2]
C2985478
patient only carries a hboc mutation that is classified as "polymorphism" of "favor polymorphism"
Beschreibung

HBOC Mutation Singular | Polymorphism

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677776
UMLS CUI [1,2]
C0026882
UMLS CUI [1,3]
C0205171
UMLS CUI [2]
C1882417
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02302742

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Triple Negative Breast Neoplasms
Item
triple negative breast cancer
boolean
C3539878 (UMLS CUI [1])
Estrogen Receptors Percentage | Progesterone Receptors Percentage | Human epidermal growth factor receptor negative
Item
er/pr <10% and her negative per current asco/cap guidelines
boolean
C0034804 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0034833 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C4087185 (UMLS CUI [3])
TNM Breast tumor staging
Item
stages i-iv
boolean
C0474926 (UMLS CUI [1])
Age
Item
any age at diagnosis
boolean
C0001779 (UMLS CUI [1])
Diagnosis Timespan
Item
patient must be within 5 years of diagnosis
boolean
C0011900 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
Patient eligible for clinical trial Independent of Genetic testing
Item
eligible regardless of genetic testing status
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C0679560 (UMLS CUI [1,3])
Genetic testing Recommended
Item
genetic testing recommended for patients meeting nccn and medicare guidelines
boolean
C0679560 (UMLS CUI [1,1])
C0034866 (UMLS CUI [1,2])
ID.8
Item
and/or
boolean
Germ-Line Mutation Carrier
Item
germline mutation carriers
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Genes | BRCA gene | PTEN gene | TP53 gene | PALB2 gene | Patient eligible for clinical trial Independent of Cancer site
Item
patients with deleterious or uncertain mutations in hboc genes (brca, pten, p53,-palb2 etc) are eligible regardless of type/site of cancer
boolean
C0677776 (UMLS CUI [1,1])
C0017337 (UMLS CUI [1,2])
C0596223 (UMLS CUI [2])
C0694888 (UMLS CUI [3])
C0079419 (UMLS CUI [4])
C1835898 (UMLS CUI [5])
C1302261 (UMLS CUI [6,1])
C0332291 (UMLS CUI [6,2])
C0872338 (UMLS CUI [6,3])
Healthy Volunteers Mutation | Patient eligible for clinical trial
Item
healthy patients harboring mutations also eligible
boolean
C1708335 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C1302261 (UMLS CUI [2])
Time limit Absent | Cancer diagnosis | Enrollment
Item
there is no time limit from the time of diagnosis of cancer and enrollment.
boolean
C0332186 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0920688 (UMLS CUI [2])
C1516879 (UMLS CUI [3])
Patient eligible for clinical trial Independent of Cancer History
Item
eligible regardless of personal history of cancer
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C1512706 (UMLS CUI [1,3])
Exclusion Criteria
Item
exclusion criteria include:
boolean
C0680251 (UMLS CUI [1])
Triple Negative Breast Neoplasm Previous
Item
triple negative breast cancer -patient is not within five years of diagnosis
boolean
C3539878 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Germ-Line Mutation Carrier
Item
germline mutation carriers:
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Mutation Singular | Polymorphism
Item
patient only carries a hboc mutation that is classified as "polymorphism" of "favor polymorphism"
boolean
C0677776 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,3])
C1882417 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video